Table 7.

Demographic characteristics and anatomical follow-up parameters of Group 4 (natural course).

Patient No	Genetic mutation	Eye	Horizontal EZW		Vertical EZW		FAF field
			Time0	Time1	Time0	Time1	Time0	Time1
1	RHO	R	3.74	3.06	3.41	1.91	8.6	5.1
		L	3.46	2.71	3.61	2.74	8.9	5.4
2	PCARE	R	8.30	5.81	7.77	5.43	46.4	29.8
		L	8.30	5.81	7.97	5.57	46.8	30.1
3	RPGR	R	2.12	0.81	2.76	1.37	4.7	0.9
		L	2.71	1.32	3.01	1.56	1.9	1.3
4	USH2A	R	7.45	6.33	5.68	4.81	62.9	53.8
		L	8.24	6.96	7.98	6.81	71.8	61.5
5	PDE6B	R	3.73	2.35	2.87	2.01	9.1	6.2
		L	3.79	2.37	3.68	2.76	14.8	8.9
6	BBS2	R	1.92	1.12	1.82	1.03	3.8	1.4
		L	1.60	1.14	1.55	0.86	2.2	0.81
7	PDE6B	R	3.11	2.06	3.50	2.74	10.1	6.2
		L	3.02	2.01	3.41	2.54	9.8	4.6
8	RHO	R	5.75	4.82	5.01	4.24	26.1	16.6
		L	5.69	4.78	5.22	4.37	25.9	16.5
9	RP1	R	2.40	1.98	2.40	2.00	4.2	3.7
		L	2.70	2.14	2.60	2.06	4.8	4.0
10	USH2A	R	5.08	4.24	4.98	4.16	22.6	16.9
		L	4.98	4.19	4.71	4.14	17.2	16.6
11	BBS6	R	1.34	0.91	1.38	1.02	1.4	1.1
		L	1.29	0.87	1.30	0.90	1.2	0.84
12	TULP1	R	1.77	1.24	1.53	1.10	3.9	3.1
		L	1.54	1.12	1.70	1.25	3.2	2.9
13	RHO	R	2.86	2.41	2.77	2.38	5.6	5.0
		L	2.76	2.34	2.65	2.32	5.1	4.6
14	RHO	R	2.33	2.02	2.00	1.74	4.1	3.9
		L	1.97	1.71	1.89	1.69	3.7	3.1
15	EYS	R	1.88	1.42	1.88	1.43	3.6	2.2
		L	2.05	1.78	2.49	2.32	5.7	4.6
16	ABCA4	R	2.53	1.81	2.48	1.78	6.1	5.2
		L	2.50	1.79	2.48	1.78	6.0	5.1

Time0 (baseline): initial examination.

Time1: 36th month examination.

Abbreviations: EZW, ellipsoid zone width (mm); FAF, fundus autofluorescence (mm²).